Table 5 Risk factors for mortality within 90 days of study entry among patients with confirmed tuberculosis (n = 139)
| Â | Unadjusted hazard ratio (95% CI) | Log-rank | Adjusted hazard ratio (95% CI) | Log-rank |
|---|---|---|---|---|
Age (for each year decrease) | 1.01 (0.97–1.06) | 0.545 |  |  |
Gender | ||||
 Female | 1.00 | 0.093 | 1.00 | 0.205 |
 Male | 2.17 (0.88–5.35) |  | 1.80 (0.73–4.48) |  |
ART status | ||||
 Current ART | 1.00 | 0.922 |  |  |
 ART naive | 1.18 (0.43–3.24) |  |  |  |
 Interrupted ART | 1.29 (0.32–5.18) |  |  |  |
CD4 category (cells/uL) | ||||
 ≥150 | 1.00 | 0.261 |  |  |
 199–149 | 3.30 (0.74–14.75) |  |  |  |
 50–99 | 1.58 (0.26–9.48) |  |  |  |
 <50 | 2.92 (0.80–10.61) |  |  |  |
HIV viral load (log copies/mL) | ||||
 <400 | 1.00 | 0.683 |  |  |
 ≥400 | 1.30 (0.37–4.48) |  |  |  |
C-reactive protein (mg/L) | ||||
 <50 | 1.00 | 0.262 |  |  |
 ≥50 | 3.16 (0.42–23.47) |  |  |  |
LAM-positive | ||||
 No | 1.00 | 0.007 | 1.00 | 0.004 |
 Yes | 3.56 (1.35–9.36) |  | 4.20 (1.50–11.75) |  |
RIF-resistant TB | ||||
 No | 1.00 | 0.082 | 1.00 | 0.032 |
 Yes | 4.90 (1.13–21.24) |  | 8.41 (1.74–40.67) |  |